Enanta Pharmaceuticals: Overview of Fiscal First Quarter Earnings
Enanta Pharmaceuticals Reports First Quarter Financial Results
Enanta Pharmaceuticals Inc., headquartered in Watertown, Massachusetts, announced on Monday that it recorded a net loss of $11.9 million for its fiscal first quarter.
The company reported a loss of 42 cents per share during this period.
Revenue for the quarter reached $18.6 million for the biotechnology firm.
This article was produced by Automated Insights utilizing data provided by Zacks Investment Research.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Target's Beat: A Margin Story or the Start of a Real Turnaround?
Marex Group PLC (MRX) Q4 Results Surpass Expectations for Earnings and Revenue
XRP Price Decouples From Bitcoin as Volume Jumps 24%
Multi-Year Shiba Inu (SHIB) Bottom Almost Reached: What to Expect After It
Trending news
MoreCrypto prices
More
